Detalles de la búsqueda
1.
A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population.
Nephrol Dial Transplant
; 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520170
2.
Counting the lifetime cost of obesity: Analysis based on national England data.
Diabetes Obes Metab
; 26(4): 1464-1478, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38312024
3.
Failure to control conventional cardiovascular risk factors in women with type 2 diabetes might explain worse mortality.
Diabetes Metab Res Rev
; 39(8): e3695, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592876
4.
Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies.
Diabetes Obes Metab
; 25(2): 501-515, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36239122
5.
Diabetes foot complications and standardized mortality rate in type 2 diabetes.
Diabetes Obes Metab
; 25(12): 3662-3670, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37722968
6.
Postdischarge venous thromboembolism following hospital admission with COVID-19.
Blood
; 136(11): 1347-1350, 2020 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32746455
7.
What is the impact of microvascular complications of diabetes on severe COVID-19?
Microvasc Res
; 140: 104310, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34979154
8.
GLP-1 receptor agonist use during hospitalisation: Better glycaemic control compared to premixed insulin.
Diabetes Metab Res Rev
; 38(8): e3574, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36052434
9.
The change in glycaemic control immediately after COVID-19 vaccination in people with type 1 diabetes.
Diabet Med
; 39(4): e14774, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34936128
10.
Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study.
Diabetes Obes Metab
; 24(7): 1310-1318, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373891
11.
Comparison of the QuikRead go® point-of-care faecal immunochemical test for haemoglobin with the FOB Gold Wide® laboratory analyser to diagnose colorectal cancer in symptomatic patients.
Clin Chem Lab Med
; 60(1): 101-108, 2022 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34679264
12.
Lessons learnt from the variation across 6741 family/general practices in England in the use of treatments for hypogonadism.
Clin Endocrinol (Oxf)
; 94(5): 827-836, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33420743
13.
Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism.
Diabet Med
; 38(5): e14452, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33165941
14.
Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre.
Colorectal Dis
; 23(7): 1622-1629, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33068489
15.
Diagnostic accuracy of point of care faecal immunochemical testing using a portable high-speed quantitative analyser for diagnosis in 2-week wait patients.
Colorectal Dis
; 23(9): 2376-2386, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34157205
16.
Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID-19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medication.
Int J Clin Pract
; 75(12): e14714, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34375490
17.
HDL-apoA-I kinetics in response to 16 wk of exercise training in men with nonalcoholic fatty liver disease.
Am J Physiol Endocrinol Metab
; 318(6): E839-E847, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32286882
18.
Diabetes, obesity and COVID-19: A complex interplay.
Diabetes Obes Metab
; 22(10): 1892-1896, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32627299
19.
Is 3D faster and safer than 4K laparoscopic cholecystectomy? A randomised-controlled trial.
Surg Endosc
; 34(4): 1729-1735, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31321536
20.
3D laparoscopy does not reduce operative duration or errors in day-case laparoscopic cholecystectomy: a randomised controlled trial.
Surg Endosc
; 34(4): 1745-1753, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31312963